Cite
Fluoropolymer-MOF Hybrids with Switchable Hydrophilicity for 19 F MRI-Monitored Cancer Therapy.
MLA
Wang, Qiaoyun, et al. “Fluoropolymer-MOF Hybrids with Switchable Hydrophilicity for 19 F MRI-Monitored Cancer Therapy.” ACS Nano, vol. 17, no. 9, May 2023, pp. 8483–98. EBSCOhost, https://doi.org/10.1021/acsnano.3c00694.
APA
Wang, Q., Yu, Y., Chang, Y., Xu, X., Wu, M., Ediriweera, G. R., Peng, H., Zhen, X., Jiang, X., Searles, D. J., Fu, C., & Whittaker, A. K. (2023). Fluoropolymer-MOF Hybrids with Switchable Hydrophilicity for 19 F MRI-Monitored Cancer Therapy. ACS Nano, 17(9), 8483–8498. https://doi.org/10.1021/acsnano.3c00694
Chicago
Wang, Qiaoyun, Ye Yu, Yixin Chang, Xin Xu, Min Wu, Gayathri R Ediriweera, Hui Peng, et al. 2023. “Fluoropolymer-MOF Hybrids with Switchable Hydrophilicity for 19 F MRI-Monitored Cancer Therapy.” ACS Nano 17 (9): 8483–98. doi:10.1021/acsnano.3c00694.